Ambient Storage Stabilizer for Biological Samples

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for storing biological samples, such as nucleic acids and proteins, face challenges in maintaining biological activity over extended periods without refrigeration, especially under extreme environmental conditions, leading to degradation and loss of functional integrity.

Innovation Solution

A composition comprising specific compounds, precipitating agents, lower alcohols, chaotropes, chelating agents, reducing agents, and pH buffers is used to stabilize nucleic acid and protein molecules, allowing for storage at ambient temperatures without refrigeration, preventing degradation and maintaining biological activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If biological samples are stored at low temperatures (−20°C to −80°C) to prevent degradation, then nucleic acid and protein stability is improved, but storage cost and equipment complexity increase significantly

Engineering Contradiction:
Improvenucleic acid and protein stabilityVSAvoidstorage equipment complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The invention changes the chemical parameters of the storage buffer by incorporating specific stabilizing compounds (e.g., BSA, gelatin, specific salts, and reducing agents) to create optimal chemical conditions that protect biomolecules at ambient temperatures, eliminating the need for temperature-controlled equipment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses inexpensive chemical stabilizers and simple buffer components that can be easily prepared and discarded, replacing expensive and complex refrigeration equipment with simple chemical protection systems that require no maintenance or energy input

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If biological samples are transported without refrigeration to simplify logistics, then ease of operation is improved, but sample degradation increases

Engineering Contradiction:
Improvetransportation convenienceVSAvoidsample integrity
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The invention performs preliminary stabilization by adding protective compounds and optimizing buffer conditions before sample collection, ensuring that biomolecules are protected from degradation throughout the entire transport process without requiring subsequent temperature control

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention introduces chemical intermediaries (stabilizing compounds, protective proteins, and buffer agents) that mediate between the sample and environmental stressors, protecting biomolecules from temperature fluctuations and degradation during transport

Inventive Principle:
Principle #24Intermediary (Mediator)

3Use of energy by stationary object

If nucleic acids are stored on cellulose membranes at room temperature to eliminate refrigeration, then storage cost decreases, but material recovery loss increases substantially

Engineering Contradiction:
Improverefrigeration energy consumptionVSAvoidnucleic acid recovery loss
Core Design Contradiction:
Use of energy by stationary objectVSLoss of substance

Solution Approach 1:

The invention extracts nucleic acids from cellulose membrane binding and instead stabilizes them in liquid or semi-liquid buffer solutions, eliminating the adsorption-induced loss while maintaining ambient temperature storage capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses composite buffer systems containing multiple protective components (proteins, salts, reducing agents, and chelating agents) that work synergistically to stabilize nucleic acids in solution, preventing degradation without requiring membrane binding

Inventive Principle:
Principle #40Composite materials

4Ease of manufacture

If standard buffer solutions are used for sample storage, then ease of manufacture is improved, but sample stability at ambient temperature deteriorates

Engineering Contradiction:
Improvestorage solution preparationVSAvoidambient temperature stability
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The invention modifies buffer parameters by adding specific stabilizing compounds at optimized concentrations, creating a chemically enhanced formulation that maintains simplicity of preparation while dramatically improving ambient temperature stability of biomolecules

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively stabilizes DNA and RNA for up to 70% recovery and polypeptides for extended periods, preventing degradation and maintaining biological activity, even at room temperature, thus addressing the limitations of existing storage methods.

Implementation Method 1

A composition comprising specific compounds, precipitating agents, lower alcohols, chaotropes, chelating agents, reducing agents, and pH buffers is used to stabilize nucleic acid and protein molecules, allowing for storage at ambient temperatures without refrigeration, preventing degradation and maintaining biological activity

Methodology Applied
Scientific EffectChemical stabilization:

Data Source

PatentUS9999217B2Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures
Publication Date: 2018.06.19 BIOMATRICA INC
  • US9999217B2 patent drawing
  • US9999217B2 patent drawing
  • US9999217B2 patent drawing

AI summary

Compositions and methods are disclosed for substantially liquid, gel, suspension, slurry, semisolid and/or colloid storage of biological samples following admixture with the herein disclosed storage composition, permitting substantial recovery of biological activity following storage without refrigeration. In certain embodiments, unfractionated blood or tissue samples may be stored without refrigeration for weeks, months or years in a form that permits recovery of intact DNA, RNA or protein components following the storage period.